世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および米国の臓器移植診断薬市場規模、現状、予測2021-2027年


Global and United States Organ Transplant Diagnostics Market Size, Status and Forecast 2021-2027

移植診断薬の需要は、主に官民連携による重点的な研究活動への資金提供の増加、感染症の負担増、移植手術数の増加、移植診断薬分野における技術の進歩などの要因により、増加することが予想されます。技術別の市... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年12月3日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

移植診断薬の需要は、主に官民連携による重点的な研究活動への資金提供の増加、感染症の負担増、移植手術数の増加、移植診断薬分野における技術の進歩などの要因により、増加することが予想されます。技術別の市場区分では、分子分析技術と非分子分析技術に分けられます。分子解析技術の分野が最も大きなシェアを占めています。この部分の大部分は、短いターンアラウンドタイム、高いプログラム効率、複数サンプルの研究、リアルタイムのサンプル分析など、分子検出の利点に起因しています。

市場分析とインサイト臓器移植診断薬の世界市場
臓器移植診断薬の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
当レポートでは、業界標準の正確な分析と高いデータ保全性により、世界の臓器移植診断市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう努めています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界の臓器移植診断市場の全体的なサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の臓器移植診断市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の臓器移植診断市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の臓器移植診断の範囲と市場規模
臓器移植診断薬市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界の臓器移植診断市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
分子アッセイ技術
非分子アッセイ技術(Non-molecular Assay Technologies

アプリケーション別
独立したリファレンスラボ
病院・移植センター
研究所・学術研究機関

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
QIAGEN NV
サーモフィッシャーサイエンティフィック
BioMérieuxSA
CareDx
ルミネックス社
ディッキンソン・アンド・カンパニー
バイオフォーチュナ


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ Transplant Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Assay Technologies
1.2.3 Non-molecular Assay Technologies
1.3 Market by Application
1.3.1 Global Organ Transplant Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Independent Reference Laboratories
1.3.3 Hospitals and Transplant Centers
1.3.4 Research Laboratories and Academic Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Organ Transplant Diagnostics Market Perspective (2016-2027)
2.2 Organ Transplant Diagnostics Growth Trends by Regions
2.2.1 Organ Transplant Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Organ Transplant Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Organ Transplant Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Organ Transplant Diagnostics Industry Dynamic
2.3.1 Organ Transplant Diagnostics Market Trends
2.3.2 Organ Transplant Diagnostics Market Drivers
2.3.3 Organ Transplant Diagnostics Market Challenges
2.3.4 Organ Transplant Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Organ Transplant Diagnostics Players by Revenue
3.1.1 Global Top Organ Transplant Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Organ Transplant Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Organ Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Organ Transplant Diagnostics Revenue
3.4 Global Organ Transplant Diagnostics Market Concentration Ratio
3.4.1 Global Organ Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ Transplant Diagnostics Revenue in 2020
3.5 Organ Transplant Diagnostics Key Players Head office and Area Served
3.6 Key Players Organ Transplant Diagnostics Product Solution and Service
3.7 Date of Enter into Organ Transplant Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Organ Transplant Diagnostics Breakdown Data by Type
4.1 Global Organ Transplant Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Organ Transplant Diagnostics Forecasted Market Size by Type (2022-2027)

5 Organ Transplant Diagnostics Breakdown Data by Application
5.1 Global Organ Transplant Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Organ Transplant Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Organ Transplant Diagnostics Market Size (2016-2027)
6.2 North America Organ Transplant Diagnostics Market Size by Type
6.2.1 North America Organ Transplant Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Organ Transplant Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Organ Transplant Diagnostics Market Size by Type (2016-2027)
6.3 North America Organ Transplant Diagnostics Market Size by Application
6.3.1 North America Organ Transplant Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Organ Transplant Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Organ Transplant Diagnostics Market Size by Application (2016-2027)
6.4 North America Organ Transplant Diagnostics Market Size by Country
6.4.1 North America Organ Transplant Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Organ Transplant Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Organ Transplant Diagnostics Market Size (2016-2027)
7.2 Europe Organ Transplant Diagnostics Market Size by Type
7.2.1 Europe Organ Transplant Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Organ Transplant Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Organ Transplant Diagnostics Market Size by Type (2016-2027)
7.3 Europe Organ Transplant Diagnostics Market Size by Application
7.3.1 Europe Organ Transplant Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Organ Transplant Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Organ Transplant Diagnostics Market Size by Application (2016-2027)
7.4 Europe Organ Transplant Diagnostics Market Size by Country
7.4.1 Europe Organ Transplant Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Organ Transplant Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Organ Transplant Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Type
8.2.1 Asia-Pacific Organ Transplant Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Organ Transplant Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Organ Transplant Diagnostics Market Size by Application
8.3.1 Asia-Pacific Organ Transplant Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Organ Transplant Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Organ Transplant Diagnostics Market Size by Region
8.4.1 Asia-Pacific Organ Transplant Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Organ Transplant Diagnostics Market Size (2016-2027)
9.2 Latin America Organ Transplant Diagnostics Market Size by Type
9.2.1 Latin America Organ Transplant Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Organ Transplant Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Organ Transplant Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Organ Transplant Diagnostics Market Size by Application
9.3.1 Latin America Organ Transplant Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Organ Transplant Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Organ Transplant Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Organ Transplant Diagnostics Market Size by Country
9.4.1 Latin America Organ Transplant Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Organ Transplant Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Organ Transplant Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Type
10.2.1 Middle East & Africa Organ Transplant Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Organ Transplant Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Organ Transplant Diagnostics Market Size by Application
10.3.1 Middle East & Africa Organ Transplant Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Organ Transplant Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Organ Transplant Diagnostics Market Size by Country
10.4.1 Middle East & Africa Organ Transplant Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 QIAGEN NV
11.1.1 QIAGEN NV Company Details
11.1.2 QIAGEN NV Business Overview
11.1.3 QIAGEN NV Organ Transplant Diagnostics Introduction
11.1.4 QIAGEN NV Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.1.5 QIAGEN NV Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Organ Transplant Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 BioMérieuxSA
11.3.1 BioMérieuxSA Company Details
11.3.2 BioMérieuxSA Business Overview
11.3.3 BioMérieuxSA Organ Transplant Diagnostics Introduction
11.3.4 BioMérieuxSA Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.3.5 BioMérieuxSA Recent Development
11.4 CareDx
11.4.1 CareDx Company Details
11.4.2 CareDx Business Overview
11.4.3 CareDx Organ Transplant Diagnostics Introduction
11.4.4 CareDx Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.4.5 CareDx Recent Development
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Details
11.5.2 Luminex Corporation Business Overview
11.5.3 Luminex Corporation Organ Transplant Diagnostics Introduction
11.5.4 Luminex Corporation Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.5.5 Luminex Corporation Recent Development
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Details
11.6.2 Dickinson and Company Business Overview
11.6.3 Dickinson and Company Organ Transplant Diagnostics Introduction
11.6.4 Dickinson and Company Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.6.5 Dickinson and Company Recent Development
11.7 Biofortuna
11.7.1 Biofortuna Company Details
11.7.2 Biofortuna Business Overview
11.7.3 Biofortuna Organ Transplant Diagnostics Introduction
11.7.4 Biofortuna Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.7.5 Biofortuna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Demand for transplant diagnostic products is expected to increase, mainly due to factors such as increased public-private partnership funding for targeted research activities, increased burden of infectious diseases, increased number of transplant procedures, and technological advancements in the field of transplant diagnostics. The market segment by technology is divided into molecular and non-molecular analytical technologies. The field of molecular analysis technology has the largest market share. A large part of this part can be attributed to the benefits of molecular detection, such as short turnaround time, high program efficiency, research on multiple samples, and real-time sample analysis.

Market Analysis and Insights: Global Organ Transplant Diagnostics Market
The global Organ Transplant Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Organ Transplant Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Organ Transplant Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Organ Transplant Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Organ Transplant Diagnostics market.

Global Organ Transplant Diagnostics Scope and Market Size
Organ Transplant Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies

Segment by Application
Independent Reference Laboratories
Hospitals and Transplant Centers
Research Laboratories and Academic Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
QIAGEN NV
Thermo Fisher Scientific
BioMérieuxSA
CareDx
Luminex Corporation
Dickinson and Company
Biofortuna



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ Transplant Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Assay Technologies
1.2.3 Non-molecular Assay Technologies
1.3 Market by Application
1.3.1 Global Organ Transplant Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Independent Reference Laboratories
1.3.3 Hospitals and Transplant Centers
1.3.4 Research Laboratories and Academic Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Organ Transplant Diagnostics Market Perspective (2016-2027)
2.2 Organ Transplant Diagnostics Growth Trends by Regions
2.2.1 Organ Transplant Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Organ Transplant Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Organ Transplant Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Organ Transplant Diagnostics Industry Dynamic
2.3.1 Organ Transplant Diagnostics Market Trends
2.3.2 Organ Transplant Diagnostics Market Drivers
2.3.3 Organ Transplant Diagnostics Market Challenges
2.3.4 Organ Transplant Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Organ Transplant Diagnostics Players by Revenue
3.1.1 Global Top Organ Transplant Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Organ Transplant Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Organ Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Organ Transplant Diagnostics Revenue
3.4 Global Organ Transplant Diagnostics Market Concentration Ratio
3.4.1 Global Organ Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ Transplant Diagnostics Revenue in 2020
3.5 Organ Transplant Diagnostics Key Players Head office and Area Served
3.6 Key Players Organ Transplant Diagnostics Product Solution and Service
3.7 Date of Enter into Organ Transplant Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Organ Transplant Diagnostics Breakdown Data by Type
4.1 Global Organ Transplant Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Organ Transplant Diagnostics Forecasted Market Size by Type (2022-2027)

5 Organ Transplant Diagnostics Breakdown Data by Application
5.1 Global Organ Transplant Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Organ Transplant Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Organ Transplant Diagnostics Market Size (2016-2027)
6.2 North America Organ Transplant Diagnostics Market Size by Type
6.2.1 North America Organ Transplant Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Organ Transplant Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Organ Transplant Diagnostics Market Size by Type (2016-2027)
6.3 North America Organ Transplant Diagnostics Market Size by Application
6.3.1 North America Organ Transplant Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Organ Transplant Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Organ Transplant Diagnostics Market Size by Application (2016-2027)
6.4 North America Organ Transplant Diagnostics Market Size by Country
6.4.1 North America Organ Transplant Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Organ Transplant Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Organ Transplant Diagnostics Market Size (2016-2027)
7.2 Europe Organ Transplant Diagnostics Market Size by Type
7.2.1 Europe Organ Transplant Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Organ Transplant Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Organ Transplant Diagnostics Market Size by Type (2016-2027)
7.3 Europe Organ Transplant Diagnostics Market Size by Application
7.3.1 Europe Organ Transplant Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Organ Transplant Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Organ Transplant Diagnostics Market Size by Application (2016-2027)
7.4 Europe Organ Transplant Diagnostics Market Size by Country
7.4.1 Europe Organ Transplant Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Organ Transplant Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Organ Transplant Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Type
8.2.1 Asia-Pacific Organ Transplant Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Organ Transplant Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Organ Transplant Diagnostics Market Size by Application
8.3.1 Asia-Pacific Organ Transplant Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Organ Transplant Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Organ Transplant Diagnostics Market Size by Region
8.4.1 Asia-Pacific Organ Transplant Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Organ Transplant Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Organ Transplant Diagnostics Market Size (2016-2027)
9.2 Latin America Organ Transplant Diagnostics Market Size by Type
9.2.1 Latin America Organ Transplant Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Organ Transplant Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Organ Transplant Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Organ Transplant Diagnostics Market Size by Application
9.3.1 Latin America Organ Transplant Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Organ Transplant Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Organ Transplant Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Organ Transplant Diagnostics Market Size by Country
9.4.1 Latin America Organ Transplant Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Organ Transplant Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Organ Transplant Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Type
10.2.1 Middle East & Africa Organ Transplant Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Organ Transplant Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Organ Transplant Diagnostics Market Size by Application
10.3.1 Middle East & Africa Organ Transplant Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Organ Transplant Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Organ Transplant Diagnostics Market Size by Country
10.4.1 Middle East & Africa Organ Transplant Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Organ Transplant Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 QIAGEN NV
11.1.1 QIAGEN NV Company Details
11.1.2 QIAGEN NV Business Overview
11.1.3 QIAGEN NV Organ Transplant Diagnostics Introduction
11.1.4 QIAGEN NV Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.1.5 QIAGEN NV Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Organ Transplant Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 BioMérieuxSA
11.3.1 BioMérieuxSA Company Details
11.3.2 BioMérieuxSA Business Overview
11.3.3 BioMérieuxSA Organ Transplant Diagnostics Introduction
11.3.4 BioMérieuxSA Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.3.5 BioMérieuxSA Recent Development
11.4 CareDx
11.4.1 CareDx Company Details
11.4.2 CareDx Business Overview
11.4.3 CareDx Organ Transplant Diagnostics Introduction
11.4.4 CareDx Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.4.5 CareDx Recent Development
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Details
11.5.2 Luminex Corporation Business Overview
11.5.3 Luminex Corporation Organ Transplant Diagnostics Introduction
11.5.4 Luminex Corporation Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.5.5 Luminex Corporation Recent Development
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Details
11.6.2 Dickinson and Company Business Overview
11.6.3 Dickinson and Company Organ Transplant Diagnostics Introduction
11.6.4 Dickinson and Company Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.6.5 Dickinson and Company Recent Development
11.7 Biofortuna
11.7.1 Biofortuna Company Details
11.7.2 Biofortuna Business Overview
11.7.3 Biofortuna Organ Transplant Diagnostics Introduction
11.7.4 Biofortuna Revenue in Organ Transplant Diagnostics Business (2016-2021)
11.7.5 Biofortuna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(診断薬)の最新刊レポート

本レポートと同じKEY WORD(organ)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る